A detailed history of Atlas Private Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Atlas Private Wealth Management holds 460 shares of LLY stock, worth $344,963. This represents 0.16% of its overall portfolio holdings.

Number of Shares
460
Previous 474 2.95%
Holding current value
$344,963
Previous $276,000 29.35%
% of portfolio
0.16%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$592.2 - $792.28 $8,290 - $11,091
-14 Reduced 2.95%
460 $357,000
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $166,250 - $222,296
474 New
474 $222,000
Q2 2021

Aug 05, 2021

SELL
$180.55 - $233.54 $27,985 - $36,198
-155 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $16,572 - $20,526
155 New
155 $20,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Atlas Private Wealth Management Portfolio

Follow Atlas Private Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Private Wealth Management with notifications on news.